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Purpose
Despite cancer patients’ extensive use of complementary
and alternative medicine (CAM), validated instruments
to measure decision making factors related to CAM use
are lacking. We sought to develop and validate an
instrument, Decision Making in CAM (DMCAM), to
measure individual cancer patients’ perceived benefit,
barriers, and social norms related to CAM use.
Methods
The 17-item instrument was developed using the The-
ory of Planned Behavior (TPB) as a theoretical frame-
work. Literature review, qualitative interviews, expert
content review, and cognitive interviews were used to
develop the instrument which was then administered to
317 outpatient oncology patients. Reliability and validity
of DMCAM scores were examined including factor
structure, internal consistency, content, and construct
validity.
Results
The DMCAM had a 3-factor structure: expected bene-
fits, perceived barriers, and subjective norms related to
decision making about CAM use by cancer patients.
These three domains had Eigen values of 4.79, 2.37,
and 1.43, and together explained over 57.2% of the var-
iance. The 4-item expected benefits, 7-item perceived
barriers, and 4-item subjective norms domain scores
each had an acceptable internal consistency (Cron-
bach’s alpha coefficient) of 0.91, 0.76, and 0.75 respec-
tively. As expected, CAM users had higher expected
benefits (65.2 vs. 52.1, p<0.001), lower perceived bar-
riers (43.9 vs. 50.7, p<0.001), and more positive subjec-
tive norms (52.3 vs. 45.2, p<0.001) than those who did
not use CAM.
Conclusion
The DMCAM instrument produced reliable and valid
scores that measured decision factors related to CAM
use for cancer patients. Incorporation of the DMCAM
in prospective research will help to determine how these
factors may affect CAM use during cancer treatment
and survivorship. Further, the use of this instrument in
racially/ethnically diverse groups may help explain the
variations in CAM use by cancer patients in specific
populations.
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